Millions of people throughout the U.S. struggle with depression. Some of them find that, despite their best efforts and desire to get well, the condition resists treatment. The best medications and therapies may seem to produce only temporary effects.
Luckily, there are options that may be helpful to Californians in this situation.
When people look for help with depression, they might start by searching online for “depression studies near me.” If they did, they would discover that new, innovative treatments are available for those who feel like they have tried everything.
Depression clinical research trials give patients the opportunity to access medication that may take years to reach the open market. By using these treatments, depression patients can not only benefit themselves, but improve the outlook for many others with similar challenges.
Clinical Trials for Depression are Making a Difference in Treatment
About 17 percent of people in the United States will experience depression at some point. While there are a number of common therapeutic drugs for depression, they do not work for everyone. In all, there are still many mysteries around how depression starts and how it can be relieved. One of the problems with depression is that it often recurs with time.
Luckily, there are many new directions in depression research that may prove fruitful:
Monoamine Transmitter Stimulus
One longstanding theory about depression is that it represents a brain chemical imbalance in which key neurotransmitters associated with happiness – including dopamine and serotonin – do not function as expected. Recent research has shed much more light on the action of serotonin in particular. By isolating and screening for genetic factors, it may soon be possible to not only predict the likely incidence of depression, but optimize treatment based on genetic risks.
Neuroendocrine Hormone Treatment
The endocrine system functions to regulate the production and distribution of hormones. These hormones, in turn, are chemical messengers that maintain the operations of many organs and body systems. Problems with pituitary and thyroid function may facilitate or worsen depression. Until recently, these hormonal systems were mainly understood for their effect on cell growth and metabolism. Hormone rebalancing may soon be a viable intervention for depression.
Glutamate Inhibition
Many neurochemicals have been found to have a role in depression. By suppressing the production of certain chemicals, antidepressant effects are seen. One of these is glutamate, a neurotransmitter that serves various excitatory functions. Depressed patients typically have more glutamate than their non-depressed peers.
Synergy Research Centers
Paid clinical studies are an excellent way to make extra income while pushing the boundaries of medical science. It is simply impossible to develop new horizons of treatment without the help of study volunteers. Contact Synergy Research Centers or enroll in a study today.
[fusion_builder_container hundred_percent=”yes” overflow=”visible”][fusion_builder_row][fusion_builder_column type=”1_1″ background_position=”left top” background_color=”” border_size=”” border_color=”” border_style=”solid” spacing=”yes” background_image=”” background_repeat=”no-repeat” padding=”” margin_top=”0px” margin_bottom=”0px” class=”” id=”” animation_type=”” animation_speed=”0.3″ animation_direction=”left” hide_on_mobile=”no” center_content=”no” min_height=”none”][related_posts max=”2″ template=”one_third” effect=”none”]
[/related_posts][/fusion_builder_column][/fusion_builder_row][/fusion_builder_container]